Cargando…

Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study

Impulse control disorders (ICD) in Parkinson’s disease (PD) frequently occur, not always as a direct consequence of dopaminergic medication. This study investigated premorbid personality traits and behavioural characteristics in non-demented PD patients with self-reported symptoms of ICD (PD-srICD)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Leplow, Bernd, Renftle, Daniela, Thomas, Mareike, Michaelis, Katja, Solbrig, Susanne, Maetzler, Walter, Berg, Daniela, Liepelt-Scarfone, Inga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2023
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902415/ https://www.ncbi.nlm.nih.gov/pubmed/36662280 http://dx.doi.org/10.1007/s00702-023-02588-8

Ejemplares similares

Effect of Fear of Falling on Mobility Measured During Lab and Daily Activity Assessments in Parkinson’s Disease
por: Atrsaei, Arash, et al.
Publicado: (2021)

Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2021)

Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study
por: Becker, Sara, et al.
Publicado: (2022)

Instrumented Functional Reach Test Differentiates Individuals at High Risk for Parkinson’s Disease from Controls
por: Hasmann, Sandra E., et al.
Publicado: (2014)

Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s Disease
por: Becker, Sara, et al.
Publicado: (2022)

Post-Cueing Deficits with Maintained Cueing Benefits in Patients with Parkinson’s Disease Dementia
por: Gräber, Susanne, et al.
Publicado: (2014)

Emergency Department Patients with Psychiatric Complaints Return at Higher Rates than Controls
por: Madsen, Troy E., et al.
Publicado: (2009)

Clinical Characteristics with an Impact on ADL Functions of PD Patients with Cognitive Impairment Indicative of Dementia
por: Liepelt-Scarfone, Inga, et al.
Publicado: (2013)

Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls
por: Pålsson, Erik, et al.
Publicado: (2017)

Influence of Different Cut-Off Values on the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease
por: Liepelt-Scarfone, Inga, et al.
Publicado: (2011)

Investigating mechanisms of cognitive control training: neural signatures of PASAT performance in depressed patients
por: Sommer, Anja, et al.
Publicado: (2021)

Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns
por: Bardowell, Sabrina A., et al.
Publicado: (2013)

Functional connectivity during cognitive control in children with autism spectrum disorder: an independent component analysis
por: Ambrosino, S., et al.
Publicado: (2014)

Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study
por: Cilia, Roberto, et al.
Publicado: (2023)

Importance of Sex Differences in Impulse Control and Addictions
por: Mitchell, Marci R., et al.
Publicado: (2015)

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
por: Toniolo, Ricardo Alexandre, et al.
Publicado: (2017)

Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity disorder: evidence for reduced NoGo anteriorization
por: Papp, Szilvia, et al.
Publicado: (2023)

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
por: Verma, Rashmi, et al.
Publicado: (2020)

Equivalence of MammaPrint array types in clinical trials and diagnostics
por: Beumer, Inès, et al.
Publicado: (2016)

Dysfunction of Self-Control in Facebook Addiction: Impulsivity Is the Key
por: Cudo, Andrzej, et al.
Publicado: (2019)

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
por: Strube, Wolfgang, et al.
Publicado: (2022)

Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions
por: Berg, Sarah A, et al.
Publicado: (2014)

The Patients' Perception of Prodromal Symptoms Before the Initial Diagnosis of Parkinson's Disease
por: Gaenslen, Alexandra, et al.
Publicado: (2011)

Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort
por: Hansen, Niels, et al.
Publicado: (2021)

Low digit ratio (2D:4D) in male suicide victims
por: Lenz, Bernd, et al.
Publicado: (2016)

The acute effects of aerobic exercise on sleep in patients with unipolar depression: a randomized controlled trial
por: Brupbacher, Gavin, et al.
Publicado: (2021)

The monoamine stabilizer (−)‐OSU6162 prevents the alcohol deprivation effect and improves motor impulsive behavior in rats
por: Fredriksson, Ida, et al.
Publicado: (2018)

An updated calculator for determining levodopa-equivalent dose
por: Nyholm, D., et al.
Publicado: (2021)

Risky decision-making and affective features of impulse control disorders in Parkinson’s disease
por: Martini, Alice, et al.
Publicado: (2017)

Effect of Fear of Falling on Turning Performance in Parkinson’s Disease in the Lab and at Home
por: Haertner, Linda, et al.
Publicado: (2018)

Comparing internet-delivered cognitive therapy and behavior therapy with telephone support for insomnia disorder: a randomized controlled trial
por: Sunnhed, Rikard, et al.
Publicado: (2019)

The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson’s disease
por: Beyle, Aline, et al.
Publicado: (2018)

Mode of delivery of Cognitive Behavioral Therapy for Insomnia: a randomized controlled non-inferiority trial of digital and face-to-face therapy
por: Kallestad, Håvard, et al.
Publicado: (2021)

Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
por: Kuoppamäki, Mikko, et al.
Publicado: (2015)

Efficacy of a stepped care approach to deliver cognitive-behavioral therapy for insomnia in cancer patients: a noninferiority randomized controlled trial
por: Savard, Josée, et al.
Publicado: (2021)

The clinical effects of digital cognitive behavioral therapy for insomnia in a heterogenous study sample: results from a randomized controlled trial
por: Schuffelen, Jennifer, et al.
Publicado: (2023)

Impaired Trunk Stability in Individuals at High Risk for Parkinson's Disease
por: Maetzler, Walter, et al.
Publicado: (2012)

Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary care
por: Coteur, Kristien, et al.
Publicado: (2022)

Does providing feedback and guidance on sleep perceptions using sleep wearables improve insomnia? Findings from “Novel Insomnia Treatment Experiment”: a randomized controlled trial
por: Spina, Marie-Antoinette, et al.
Publicado: (2023)

Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry
por: Hansen, Niels, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rh2prt7kidq5fi5sj14dqst64b